| TTFS | ||
|---|---|---|
| Float Shrink | 11.39% | |
| Free Cash Flow Yield | 7.76% | |
| 30-Day SEC Yield | 0.42% | |
| Price/Earnings (P/E) Ratio | 14.76 | |
| Average Market Cap | $10.70 Bil |
Past Performance is not indicative of future results. TTFS statistics are for the actual TTFS security holdings as of the listed date, excluding cash. Float Shrink represents the percent change in shares outstanding. This is an average of all holdings in the portfolio as of the date shown. Free Cash Flow Yield is the free cash flow per share divided by the price of the stock. This is an average of all holdings in the portfolio as of the date shown. 30–Day SEC Yield (Standardized Yield) is an annualized yield that is calculated by dividing the investment income earned by the Fund less expenses over the most recent 30-day period by the current maximum offering price. P/E Ratio is the current ratio of the companies price to earnings. Average Market Cap represents the average market cap of all holdings in the portfolio.
AdvisorShares Press Release, AdvisorShares Announces December 2012 Distributions
Fry, Dave. "TTFS: A Hidden Gem." etfdigest.com.
50- and 200-day moving averages (MA) are a security's average closing price over the last 50 and 200 days, respectively. Moving averages are used to analyze price trends. An exponential moving average (EMA) is a moving average which places greater weight on more recent data. A market order order is a buy or sell order to be executed immediately at current market prices. A limit order is an order to buy a security at no more than a specific price, or to sell a security at no less than a specific price.
| NAV | Market Price Return | Russell 3000 Index | |
|---|---|---|---|
| 1 Month | 5.24 | 5.24 | 3.92 |
| 3 Month | 14.68 | 14.71 | 11.07 |
| YTD | 14.68 | 14.71 | 11.07 |
| 1 Year | 17.18 | 17.21 | 14.56 |
| Since Inception (10/04/2011, Annualized) | 31.81 | 31.83 | 28.83 |
Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. Returns less than one year are not annualized.
The Russell 3000 Index measures the performance of the largest 3000 U.S. companies representing approximately 98% of the investable U.S. equity market. One cannot invest directly in an index.
| NAV | Market Price Return | Russell 3000 Index | |
|---|---|---|---|
| 1 Month | 1.33 | 1.35 | 1.64 |
| 3 Month | 9.23 | 9.28 | 7.02 |
| YTD | 16.20 | 16.26 | 12.89 |
| 1 Year | 19.09 | 19.15 | 17.21 |
| Since Inception (10/04/2011, Annualized) | 31.02 | 31.06 | 28.46 |
| Ex-Date | Record Date | Pay Date | Cash Div | ST Cap Gain | LT Cap Gain | Return of Capital | Total Distribution |
|---|---|---|---|---|---|---|---|
12-24-13 | 12-27-13 | 12-31-13 | - | - | - | - | - |
12-24-12 | 12-27-12 | 12-31-12 | $0.213 | $0.123 | $0.00 | $0.00 | $0.336/per share |
12-23-11 | 12-28-11 | 12-30-11 | $0.014 | $0.00 | $0.00 | $0.00 | $0.014/per share |
Charles Biderman – Chief Executive Officer/Portfolio Manager
After earning his MBA from Harvard Business School, Mr. Biderman began his career as Alan Abelson’s assistant at Barron’s. He founded TrimTabs Investment Research in 1990 in Santa Rosa, California. TrimTabs Investment Research developed into the only independent research service that publishes detailed daily coverage of U.S. stock market liquidity. The premise of TrimTabs Investment Research’s approach is that stock prices are a function of liquidity rather than fundamental value.
Mr. Biderman holds a BA from Brooklyn College and an MBA from Harvard Business School. Mr. Biderman is interviewed regularly on CNBC and Bloomberg and is quoted frequently in the financial media, including Barron’s, The Wall Street Journal, Forbes, and Investor’s Business Daily. He is the author of TrimTabs Investing: Using Liquidity Theory to Beat the Stock Market (John Wiley & Sons, 2005). He holds a BA from Brooklyn College and an MBA from Harvard Business School.
Minyi Chen, CFA - Executive Vice President/Portfolio Manager
Mr. Chen joined TrimTabs in 2008. He is the Vice President of TrimTabs Investment Research and Portfolio Manager of TrimTabs Float Shrink ETF. He is responsible for the management of quantitative research, marketing, technology, sales and operations. Mr. Chen began his career as an international finance manager at ZTE Corporation, a prominent provider of telecommunications solutions in 2005.
Born in Shanghai, Mr. Chen holds a B.A. from Shanghai International Studies University in China and a M.B.A from Northwestern Polytechnic University in California. He is a Chartered Financial Analyst (CFA) charterholder. Mr. Chen speaks English and Chinese.
Symbol
TTFS
Exchange
NYSE Arca
Inception Date
10/04/2011
CUSIP
00768Y818
Indicative Value
TTFS.IV
Options
No
| NAV | $41.78 | Closing Price | $41.83 |
| Change | $0.06 | Change | $0.10 |
| Shares Outstanding | 450,000 | Volume | 850 |
| 4PM Bid/Offer Midpoint | $41.81 | Premium/Discount | $0.03 |
| Assets Under Management | $18,802,607.64 | ||
| Premium/Discount Historical Data | |||
| Ticker | Name | Weight |
|---|---|---|
| SKS | SAKS INC | 1.16% |
| DFS | DISCOVER FINANCI | 1.05% |
| PPG | PPG INDUSTRIES INC | 1.03% |
| CY | CYPRESS SEMICON | 1.03% |
| SMTC | SEMTECH CORP | 1.03% |
| M | MACY'S INC | 1.03% |
| CSTR | COINSTAR INC | 1.02% |
| UTHR | UNITED THERAPEUTICS CORP | 1.02% |
| AZO | AUTOZONE INC | 1.02% |
| VIAB | VIACOM INC - CLASS B | 1.02% |
Shares are bought and sold at market price (closing price) not NAV and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined), and do not represent the return you would receive if you traded at other times. Holdings and allocations are subject to risks and to change. A holding identified with an "MM" at the end of its name indicates it is a Money Market fund.
Management Fee
0.99%
Other Expenses
1.35%
Gross Expense Ratio
2.34%
Fee Waiver and/or Expense Reimbursement
1.35%
Net Expense Ratio
0.99%*